Injectable Collagen Bone Graft
Injectable collagen-based bone graft options from the Graftend and Goalie product families.
- Product type
- Bone Graft & Biomaterials
- Application
- Bone Graft & Biomaterials
- Manufacturer / Brand
- Socko Medical Co., Ltd.
- Regulatory
- Graftend TFDA No. 007887 / Goalie TFDA No. 008321
Injectable Collagen Bone Graft
This product family groups the injectable configurations of Socko Medical's collagen-based bone graft portfolio. Graftend and Goalie are supplied in distinct approved fill volumes and are designed for syringe-based delivery into suitable bone defects or gaps according to each product's approved Instructions for Use.
Injectable presentation
Graftend and Goalie product options
Sterile single-use configurations
Syringe-based delivery workflow
Models & specifications
Configurations shown here are a website summary. Use the current approved product documentation for final model selection and procedural details.
Graftend Injectable: 3 mL
Goalie Injectable: 1.5 mL
Model-specific preparation and handling requirements follow the approved IFU
Sterile, single use; refer to the applicable approved IFU and labeling for each product.
Indications overview
The points below summarize the product family. Final patient selection and clinical use must follow the applicable approved labeling and Instructions for Use.
Filling suitable bone defects or gaps as described in the approved IFU
Injectable handling for sites where syringe-based delivery is clinically appropriate
Use as a graft material rather than a structural load-bearing implant
Injectable Collagen Bone Graft
Product imagery is provided for portfolio identification. Model-specific components, dimensions and technique should be confirmed against current approved documentation.
Contact Summit Biomed →